CureVac (CVAC) News Today $4.41 -0.05 (-1.12%) Closing price 06/6/2025 04:00 PM EasternExtended Trading$4.43 +0.02 (+0.36%) As of 06/6/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CVAC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period CureVac (NASDAQ:CVAC) Trading Down 4.7% - Here's What HappenedCureVac (NASDAQ:CVAC) Trading Down 4.7% - What's Next?June 4, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up - Here's What HappenedCureVac (NASDAQ:CVAC) Shares Gap Up - Here's WhyJune 3, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Trading Up 5.3% - Time to Buy?CureVac (NASDAQ:CVAC) Trading 5.3% Higher - Still a Buy?May 30, 2025 | marketbeat.comJMP Securities Reaffirms "Market Outperform" Rating for CureVac (NASDAQ:CVAC)JMP Securities reaffirmed a "market outperform" rating and set a $10.00 price objective on shares of CureVac in a research report on Wednesday.May 29, 2025 | marketbeat.comMillennium Management LLC Sells 771,136 Shares of CureVac (NASDAQ:CVAC)Millennium Management LLC trimmed its position in CureVac (NASDAQ:CVAC - Free Report) by 31.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,647,037 shares of the company's stoMay 29, 2025 | marketbeat.comJMP Securities Reiterates "Market Outperform" Rating for CureVac (NASDAQ:CVAC)May 29, 2025 | americanbankingnews.comWe Think CureVac's (NASDAQ:CVAC) Robust Earnings Are ConservativeMay 27, 2025 | finance.yahoo.comBNP Paribas Financial Markets Takes $585,000 Position in CureVac (NASDAQ:CVAC)BNP Paribas Financial Markets acquired a new stake in shares of CureVac (NASDAQ:CVAC - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 171,682 shares of the company's stock, valued at approximately $585May 26, 2025 | marketbeat.comFY2025 EPS Estimates for CureVac Boosted by Leerink PartnrsCureVac (NASDAQ:CVAC - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2025 earnings estimates for shares of CureVac in a note issued to investors on Tuesday, May 20th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings per share of ($0.68)May 25, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Sold by Point72 Asset Management L.P.Point72 Asset Management L.P. trimmed its position in CureVac (NASDAQ:CVAC - Free Report) by 43.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 440,509 shares of the company's stock after selling 339,496 shares duringMay 24, 2025 | marketbeat.comEarnings Beat: CureVac N.V. (NASDAQ:CVAC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsMay 23, 2025 | finance.yahoo.comCureVac (NASDAQ:CVAC) Shares Gap Down - Here's WhyCureVac (NASDAQ:CVAC) Shares Gap Down - Time to Sell?May 23, 2025 | marketbeat.comCautious Hold Rating for CureVac Amid Uncertain Revenue ProjectionsMay 23, 2025 | tipranks.comCureVac N.V. Reports Q1 2025 Financial Results Amid Strategic RestructuringMay 21, 2025 | tipranks.comCureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains TractionMay 20, 2025 | benzinga.comCureVac (CVAC) to Release Earnings on ThursdayCureVac (NASDAQ:CVAC) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 22. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-22-curevac-stock/)May 17, 2025 | marketbeat.comBioNTech (BNTX) Faces Ongoing Patent Challenge with CureVac | BNTX Stock NewsMay 15, 2025 | gurufocus.comAlyeska Investment Group L.P. Grows Stake in CureVac (NASDAQ:CVAC)Alyeska Investment Group L.P. lifted its stake in CureVac (NASDAQ:CVAC - Free Report) by 25.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 500,000 shares of the company's stock after purchasing an additMay 9, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?CureVac (NASDAQ:CVAC) Shares Gap Up - Time to Buy?May 5, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Price Target Lowered to $12.00 at UBS GroupUBS Group decreased their target price on shares of CureVac from $13.00 to $12.00 and set a "buy" rating on the stock in a research report on Wednesday.May 2, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Shares Up 7.7% - Still a Buy?CureVac (NASDAQ:CVAC) Trading 7.7% Higher - Time to Buy?April 30, 2025 | marketbeat.comCureVac (CVAC) Target Price Reduced by UBS Analyst | CVAC Stock NewsApril 30, 2025 | gurufocus.comCureVac (NASDAQ:CVAC) Shares Gap Up - Here's WhyCureVac (NASDAQ:CVAC) Shares Gap Up - Should You Buy?April 27, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Sees Significant Increase in Short InterestCureVac (NASDAQ:CVAC - Get Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 4,850,000 shares, a growth of 19.5% from the March 15th total of 4,060,000 shares. Based on an average trading volume of 812,400 shares, the short-interest ratio is presently 6.0 days. Approximately 5.2% of the shares of the company are sold short.April 23, 2025 | marketbeat.comCureVac (CVAC) to Release Quarterly Earnings on WednesdayCureVac (NASDAQ:CVAC) will be releasing earnings before the market opens on Wednesday, April 23, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=514050)April 17, 2025 | marketbeat.comCureVac (NASDAQ:CVAC) Posts Earnings ResultsCureVac (NASDAQ:CVAC - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.15) EPS for the quarter. The company had revenue of $15.44 million for the quarter. CureVac had a return on equity of 21.98% and a net margin of 20.72%.April 14, 2025 | marketbeat.comCureVac’s Financial Resilience Amid Operational Challenges and Clinical Trial Uncertainties: A Hold Rating AnalysisApril 14, 2025 | tipranks.comCureVac N.V. (NASDAQ:CVAC) Q4 2024 Earnings Call TranscriptApril 12, 2025 | insidermonkey.comCureVac N.V. Earnings Call: Financial Strength Amid ChallengesApril 11, 2025 | tipranks.comQ4 2024 CureVac NV Earnings CallApril 11, 2025 | uk.finance.yahoo.comCureVac’s Promising Pipeline and Legal Wins Justify Buy RatingApril 11, 2025 | tipranks.comCureVac NV (CVAC) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ResilienceApril 11, 2025 | finance.yahoo.comCureVac Stock (CVAC) Dips Despite Promising Treatment PipelineApril 11, 2025 | tipranks.comCureVac reports Q4 revenue EUR 14.5M vs. EUR 22.6M last yearApril 10, 2025 | markets.businessinsider.comCureVac Reports 2024 Financial Results and Strategic AdvancesApril 10, 2025 | tipranks.comEQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business UpdateApril 10, 2025 | markets.businessinsider.comCureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch ModeApril 10, 2025 | msn.comCureVac N.V. (CVAC) Q4 2024 Earnings Call TranscriptApril 10, 2025 | seekingalpha.comCureVac N.V. 2024 Q4 - Results - Earnings Call PresentationApril 10, 2025 | seekingalpha.comCureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides ...April 10, 2025 | gurufocus.comCureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides ...April 10, 2025 | gurufocus.comCureVac (CVAC) Strengthens Financial Position to Boost mRNA Innovation | CVAC Stock NewsApril 10, 2025 | gurufocus.comGSK Deal Boosts CureVac's (CVAC) Cash Reserves, Ensures Financial Stability | CVAC Stock NewsApril 10, 2025 | gurufocus.comInsights Ahead: CureVac's Quarterly EarningsApril 9, 2025 | benzinga.comCureVac receives IND clearance to initiate Phase 1 trial for CVHNLCApril 8, 2025 | markets.businessinsider.comCureVac Receives FDA Clearance for Phase 1 Trial of mRNA ImmunotherapyApril 7, 2025 | tipranks.comCureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based ...April 7, 2025 | gurufocus.comIs CureVac (CVAC) the Best German Stock to Buy According to Hedge Funds?April 2, 2025 | msn.comCureVac (NASDAQ:CVAC) Stock Price Down 7.2% - What's Next?CureVac (NASDAQ:CVAC) Stock Price Down 7.2% - What's Next?April 1, 2025 | marketbeat.comCureVac (CVAC) Gets a Hold from Leerink PartnersMarch 31, 2025 | markets.businessinsider.com Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address CVAC Media Mentions By Week CVAC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVAC News Sentiment▼0.530.72▲Average Medical News Sentiment CVAC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVAC Articles This Week▼23▲CVAC Articles Average Week Get CureVac News Delivered to You Automatically Sign up to receive the latest news and ratings for CVAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRUS News Today RYTM News Today AKRO News Today RNA News Today PTCT News Today CYTK News Today SRPT News Today KRYS News Today ACAD News Today SWTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVAC) was last updated on 6/8/2025 by MarketBeat.com Staff From Our PartnersNext “Midnight Tweet” From Could Trigger Massive GainsWhen President Trump hits the send button... GET READY! His next “Midnight Tweet” could help Americans t...Monument Traders Alliance | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CureVac Please log in to your account or sign up in order to add this asset to your watchlist. Share CureVac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CVAC Stock Free CVAC Stock Alerts